2. Cadmium Tolerable Intake Level and Toxicity Threshold Level
The Joint FAO/WHO Expert Committee on Food Additives and Contaminants (JECFA) considered the kidney to be the critical target of Cd toxicity
[14]. By definition, the provisional tolerable weekly intake (PTWI) for a chemical with no known biological function is an estimate of the amount that can be ingested weekly over a lifetime without an appreciable health risk. In 2010, the PTWI for Cd was amended to a tolerable monthly intake (TMI) of 25 μg per kg body weight per month, equivalent to 0.83 μg per kg body weight per day. Similarly, a Cd excretion rate of 5.24 μg/g creatinine was adopted as a nephrotoxicity threshold value
[14].
The tolerable intake level derived by JECFA was based on a risk assessment model that considered an increase in the excretion rate of the low-molecular-weight protein β
2-microglubulin (β
2M) above 300 μg/g creatinine to be a “critical” endpoint. The European Food Safety Authority (EFSA) accepted the same endpoint. However, the EFSA designated a Cd excretion rate of 1 μg/g creatinine as the toxicity threshold with their inclusion of an uncertainty factor (safety margin), where an intake of 0.36 μg/kg body weight per day for 50 years was derived as an acceptable Cd ingestion level or reference dose (RfD)
[15][16][15,16]. In theory, a threshold of toxicity is defined as the highest dose that does not produce an adverse effect in the most sensitive organ
[17].
In a recent assessment, β
2M excretion levels of 100–299, 300–999, and ≥1000 μg/g creatinine were associated with 4.7-, 6.2- and 10.5-fold increases in the risk of an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73 m
2, commensurate with CKD
[18]. Thus, a cut-off value for an elevation of β
2M excretion above 300 μg/g creatinine does not appear to be an early warning sign of the nephrotoxicity of Cd. The utility of β
2M excretion as a toxicity criterion to derive a toxicity threshold level for Cd is questionable.
A further discussion on β2M excretion as a marker of tubulopathy is provided in Section 4.4.
3. Organs Susceptible to Cadmium Toxicity
3.1. Fate of Cadmium in the Body
As
Figure 1 depicts, ingested Cd is absorbed by the intestine and transported via the portal blood system to the liver, where its uptake induces the synthesis of metallothionein (MT) and the formation of CdMT complexes
[19]. Later, hepatic CdMT is released into the systemic circulation. The fraction of absorbed Cd not taken up by hepatocytes in the first pass reaches systemic circulation and is taken up by tissues and organs throughout the body, including the kidneys, pancreas
[20], ovaries
[21] and testes
[22].
Figure 1. Multiple toxicity targets of cadmium. Ingested Cd is absorbed and transported to liver, where synthesis of MT is induced, and CdMT is formed. The fraction of absorbed Cd not taken up by hepatocytes in the first pass reaches systemic circulation and is taken up and accumulated by cells throughout the body. After glomerular filtration, CdMT is reabsorbed by kidney tubular cells. Other forms of filtered Cd can be reabsorbed by the kidney nephron transporters for iron, zinc, manganese, and calcium. Abbreviations: Cd—cadmium; MT—metallothionein; CdMT—cadmium-metallothionein complex; α1MG—α1-microgloulin; β2MG—β2-microglobulin; GSH—glutathione; ALT—alanine aminotransferase; AST—aspartate aminotransferase; GFR—glomerular filtration rate; CKD—chronic kidney disease.
The liver serves as an endogenous source of Cd
2+ ions of dietary origin. From here, they are released and redistributed to kidneys as CdMT. In the circulation, less than 10% of Cd is present in plasma, and the remainder is in erythrocytes, where most Cd in whole blood is found. The whole-blood Cd level is indicative of recent exposure because the average lifespan of erythrocytes is 120 days
[23].
In theory, Cd in non-MT forms can be taken up by all nucleated cells because they have the capacity to assimilate all the metals required for normal cellular metabolism and function. However, most cells do not take up CdMT because they lack the requisite mechanisms for protein internalization. Kidney proximal tubular epithelial cells provide an exception to this rule because of their capacity for receptor-mediated endocytosis, which facilitates the reabsorption of virtually all filtered proteins
[24][25][24,25]. Filtered Cd in non-MT forms may be reabsorbed through many other nephron transporter systems
, detailed in Section 4.2.
3.2. Target Organ Toxicity Identified from U.S. NHANES
As discussed in
Section 2 above
contents, an increase in β
2M excretion above 300 μg/g creatinine was used as an endpoint in the health-risk assessment of Cd in the human diet, and urinary Cd excretion levels below 5.24 µg Cd/g creatinine were identified as the body burdens that were not associated with a change in β
2M excretion
[14]. Consequently, renal tubular dysfunction has become the most frequently reported adverse effect of environmental Cd exposure. However, many population-based studies in many countries and the U.S. general population study known as National Health and Nutrition Examination Survey (NHANES) have provided ample evidence that Cd exposure may impact the functions of many organ systems at Cd excretion levels below 5 µg/g creatinine.
NHANES is a cross-sectional study that has provided data on levels of exposure to more than 200 chemicals
[26]. Urinary and blood Cd levels were quantified via a standardized methodology that enables the comparison of data across NHANES cycles
[26]. The average Cd consumption estimated for the U.S. general population was 4.63 μg/d
[27]. This figure was based on 24 h dietary recalls obtained for NHANES 2007–2012 participants aged 2 years and older (
n = 12,523), plus the Cd levels of 260 food items in the 2006–2013 market basket surveys
[27]. Cereals and bread, leafy vegetables, potatoes, legumes and nuts, stem/root vegetables, and fruits contributed to 34%, 20%, 11%, 7%, and 6% of total intake, respectively. Foods that contain relatively high Cd levels are spaghetti, bread, potatoes, and potato chips which contributed the most to total Cd intake, followed by lettuce, spinach, tomatoes, and beer. Lettuce was a main Cd source for White people and Black people. Tortillas and rice were the main Cd sources for Hispanic Americans and Asians plus other ethnicities
[27].
The geometric mean, the 50th, 75th, 90th, and 95th percentile values for urinary Cd levels in the representative U.S. general population were 0.210, 0.208, 0.412, 0.678, and 0.949 µg/g creatinine, and the corresponding values for blood Cd were 0.304, 0.300, 0.500, 1.10, and 1.60 µg/L, respectively
[28]. Based on the above figures for dietary exposure and urinary and blood Cd levels, environmental Cd exposure levels in the U.S. could be considered as low.
The urinary excretion of Cd and its blood levels associated with adverse effects on the kidneys
[29][30][31][32][29,30,31,32], liver
[33][34][35][33,34,35], and pancreas
[36][37][38][36,37,38] are provided in
Table 1.
Table 1.
Kidney, liver and pancreas as targets of toxicity to chronic exposure to low-dose cadmium.